BioNTech (NASDAQ:BNTX) and Illumina (NASDAQ:ILMN): 10x Returns to Investors

The equity analysts that correctly identified BioNTech (NASDAQ:BNTX)  and Illumina (ILMN) for investors deserve a closer look.

Related Keywords

New York ,United States ,Paris ,France General ,France ,Cornell University ,Washington ,New York University ,Hambrecht Quist ,Suntrust Robinson Humphrey ,Soumit Roy ,Mizuho Soumit Roy ,Credit Suisse Group ,Nasdaq ,University Of Buffalo ,Pfizer Inc ,York University ,Oxford University ,Albert Einstein College Of Medicine ,Credit Suisse ,Neon Therapeutics Inc ,Powderject Pharmaceuticals In Oxford ,Clinical Immunology Department ,Icahn School Of Medicine At Mount Sinai ,Healthcare Analyst Of Jones Trading Institutional Services ,University Of Pennsylvania ,Jones Trading Institutional Services ,Vamil Divan ,Managing Director ,Mizuho Securities ,Senior Analyst ,Healthcare Analyst ,Jones Trading Institutional ,Vice President ,Jones Trading ,Icahn School ,Mount Sinai ,Albert Einstein College ,Wall Street Transcript ,Neon Therapeutics ,Moderna Therapeutics ,Suisse Group ,Powderject Pharmaceuticals ,Tycho Peterson ,